Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dexmedetomidine transdermal patch - Teikoku Pharma USA

Next Previous
Drug Profile

Dexmedetomidine transdermal patch - Teikoku Pharma USA

Alternative Names: 3-day dexmedetomidine patch; DMTS; TPU 006

Latest Information Update: 08 Jan 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Teikoku Pharma USA
  • Class Analgesics; Antidepressants; Anxiolytics; Behavioural disorder therapies; Drug withdrawal therapies; Hypnosedatives; Imidazoles; Non-opioid analgesics; Sleep disorder therapies; Small molecules
  • Mechanism of Action Alpha 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Agitation; Postoperative pain

Most Recent Events

  • 16 Sep 2025 Phase-II clinical trials in Agitation in USA (Transdermal) (NCT06052254)
  • 25 Sep 2023 Teikoku Pharma plans a phase II trial for Agitation (Transdermal, Patch) in December 2023 (NCT06052254)
  • 25 Sep 2023 Teikoku Pharma plans a phase II trial for Agitation (Transdermal, Patch) (NCT06052254)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top